Recombinant Human Angiogenin

Recombinant Human Angiogenin

Product No.: A339

[product_table name="All Top" skus="A339"]

- -
- -
Alternate Names
ALS9, HEL168, RNASE4, RNASE5, MGC22466, MGC71966
Product Type
Recombinant Protein
Expression Host
E. coli Cells
Species
Human

- -
- -
Product Size
- -
- -

Background

Angiogenin (Ang), also known as ALS9, is a member of the ribonuclease superfamily. It exhibits both angiogenic and non-angiogenic activities and is involved in endothelial cell migration, proliferation and differentiation. Ang shares approximately 35% amino acid sequence identity with pancreatic RNase. Although Ang has the same general catalytic properties as RNase A, its activity differs markedly both in magnitude and in specificity (1). The enzymatic activity of Ang appears to be essential for biological activity: replacements of important active site residues invariably diminish ribonuclease and angiogenesis activities in parallel, and a substitution that increases enzymatic activity also enhances angiogenic potency (2). Like other members of the ribonuclease superfamily, Ang is a cytotoxic agent that can eliminate cellular protein synthesis. It causes inhibition of protein synthesis by functioning as a cytotoxic tRNA-specific RNase (3). Ang stimulates capillary and umbilical vein endothelial cells to produce diacylglycerol and secrete prostacyclin by phospholipase activation (4). It is produced by a variety of tumor and normal cell types. Cells that express Ang include vascular endothelial and smooth muscle cells, fibroblasts, normal colonic epithelium, normal peripheral blood lymphocytes, lung and colonic epithelial tumor cell lines, and primary gastrointestinal adenocarcinomas. Ang is also present in normal human plasma. Research findings suggest that Ang also has antimicrobial properties (5). Researchers have identified several Ang mutations that may increase the risk of developing amyotrophic lateral sclerosis (ALS) (6).

Protein Details

Purity
>97% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<1.0 EU/µg as determined by the LAL method
Protein Accession No.
Q53X86
Amino Acid Sequence
qdnsry thfltqhyda kpqgrddryc esimrrrglt spckdintfi hgnkrsikai cenkngnphr enlriskssf qvttcklhgg spwppcqyra tagfrnvvva cenglpvhld qsifrrp
N-terminal Sequence Analysis
Gln25
State of Matter
Lyophilized
Predicted Molecular Mass
The predicted molecular weight of Recombinant Human ANG is Mr 14 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE is Mr 14 kDa.
Predicted Molecular Mass
14
Formulation
This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Country of Origin
USA
Shipping
Next Day Ambient
NCBI Gene Bank

References & Citations

1. Shapiro, R. et al. (1986) Biochemistry 25:3527
2. Shapiro, R. et al. (1990) Biochemistry 28:7401
3. Saxena, SK. et al. (1992) J. Biol. Chem. 267:21982
4. Bicknell, R. et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:1573
5. Ganz, T. et al. (2003) Nature Immunol. 4:213
6. Subramanian, V. et al. (2007) Hum. Mol. Gen. 17:130
IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.